Loading...
Cabazitaxel (Jevtana): A Novel Agent for Metastatic Castration-Resistant Prostate Cancer
OBJECTIVE: This article presents current clinical evidence supporting the use of cabazitaxel (Jevtana) in men with metastatic castration-resistant prostate cancer (mCRPC). DATA SOURCES: We conducted a literature search using abstracts from MEDLINE and PubMed (from January 1966 to December 2011) and...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MediMedia USA, Inc.
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3474423/ https://ncbi.nlm.nih.gov/pubmed/23091336 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|